Autologous Stem Cell Rescue With CD133+ Selected Cells in High-Risk Neuroblastoma
Status:
Terminated
Trial end date:
2012-09-05
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn how long it takes for certain types of
transplanted stem cells to produce new blood cells. The safety of this treatment will also be
studied. Finally, researchers want to learn if collecting the cells with the CliniMACS device
can decrease the possibility of tumor cells contaminating (appearing in) the stem cells that
are reinfused into participants.